Premium Retatrutide Peptide for Sale – Retatrutide Peptide (Triple Agonist GLP-1/GIP/Glucagon) – High Purity ≥99% | cGMP Grade for Metabolic Research

Retatrutide Peptide (LY3437943) is a next-generation synthetic 39-amino acid peptide engineered as a unimolecular triple agonist targeting three key metabolic receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This triple agonism represents a significant advancement in metabolic research beyond dual agonists like Tirzepatide.

Retatrutide activates all three receptors with balanced potency. GLP-1 and GIP activation enhance insulin secretion, reduce appetite, and improve glycemic control. Glucagon receptor activation increases energy expenditure, promotes lipolysis, and enhances thermogenesis, addressing both caloric intake and energy utilization.

Looking for Retatrutide peptide for sale from a trusted supplier? Shanghai AmbioPharm, Inc. offers high purity Retatrutide peptide manufactured under advanced, quality-controlled environments to support cutting-edge research applications. Retatrutide is widely studied in metabolic and peptide research due to its multi-receptor activity, making it a highly sought-after compound in scientific and biotech laboratories.

Our Retatrutide peptide is synthesized using pharmaceutical-grade processes to ensure ≥99% purity, excellent stability, and consistent batch performance. Each order includes a Certificate of Analysis (COA), providing full transparency and verification of product quality. With our manufacturing facility in Shanghai and USA-based distribution support, we ensure fast, secure shipping and dependable supply for both small-scale and bulk orders.

This triple mechanism uniquely targets weight loss through reduced food intake (GLP-1/GIP) and increased energy expenditure (glucagon), offering a distinct research profile for obesity and metabolic dysfunction studies.

At Shanghai AmbioPharm, Inc., we supply high-purity Retatrutide Peptide (≥99% by HPLC) for advanced metabolic research. Our cGMP-grade material is synthesized in our FDA-inspected Shanghai facility and available for fast U.S. delivery from our Clearwater, South Carolina warehouse.

Key Product Details:

• Sequence: 39-amino acid peptide with fatty acid side chain for albumin binding

• Code Name: LY3437943

• CAS Number: 2381089-83-2

• Molecular Formula: C₂₂₉H₃₄₆N₄₆O₆₆

• Molecular Weight: Approximately 4,826 g/mol

• Purity: ≥99% (HPLC)

• Form: Lyophilized white powder

• Storage: -20°C, protected from light, desiccated

• Grade Available: Non-GMP (R&D) and cGMP (clinical preparatory)

• Receptor Targets: GLP-1R, GIPR, GCGR (triple agonist)

• Key Modification: Fatty acid conjugation for extended half-life

• Research Half-Life: Approximately 6 days (once-weekly profile)

Why Choose AmbioPharm for Retatrutide Peptide?

As a global peptide CDMO, AmbioPharm combines scientific expertise with large-scale manufacturing capabilities. Choosing our Retatrutide peptide for sale ensures premium quality, trusted sourcing, and reliable delivery tailored to your research needs.

• ✅ FDA-inspected cGMP manufacturing

• ✅ Full Certificate of Analysis (COA) with each batch

• ✅ HPLC chromatogram and mass spec data included

• ✅ Verified triple agonist activity confirmation

• ✅ Low endotoxin levels (<1 EU/mg)

• ✅ U.S. warehousing – fast domestic shipping from South Carolina

• ✅ Batch-to-batch consistency for metabolic studies

Research Applications:

• Triple incretin receptor pharmacology (GLP-1/GIP/glucagon)

• Obesity and weight loss research models

• Energy expenditure and thermogenesis studies

• Glycemic control and insulin sensitivity research

• Lipolysis and fatty acid oxidation studies

• Metabolic syndrome and NAFLD research

• Appetite regulation and satiety mechanisms

• Cardiovascular and hepatic steatosis research

Mechanism of Action:
Retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors. GLP-1 and GIP promote glucose-dependent insulin secretion, delay gastric emptying, and reduce appetite via CNS pathways. Glucagon activation increases energy expenditure through hepatic glucose production, lipolysis, and thermogenesis in brown adipose tissue. The fatty acid side chain enables reversible albumin binding, extending half-life for sustained research effects.

 Intended Use: For laboratory research purposes only. Not for human consumption or clinical use without regulatory approval.

Ordering Information:

• Minimum Order Quantity (MOQ): 10mg (R&D), 10g+ (cGMP bulk)

• Lead Time: 2-3 weeks (non-GMP), 6-8 weeks (cGMP)

• Shipping: From Clearwater, SC, USA (2-5 days domestic)